Drug Profile
Research programme: epilepsy therapeutic - Penwest Pharmaceuticals
Alternative Names: PW4110Latest Information Update: 20 Aug 2009
Price :
$50
*
At a glance
- Originator Penwest Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 01 May 2007 Preclinical trials in Epilepsy in USA (unspecified route)